Sarcosinates as fluazifop-butyl adjuvants and activators
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 11, 1997
Grant Date -
N/A
app pub date -
Jul 19, 1995
filing date -
Jul 19, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An adjuvant for Fluazifop-butyl, and preferably Fluazifop-P-butyl, having increased activity, lower irritancy and lower toxicity than conventional adjuvants. The adjuvant is C.sub.8 to C.sub.22 sarcosinate or sarcosinate salt, such as sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, or combinations thereof, which is combined with Fluazifop-P-butyl and provides more effective activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully